Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer

Gastrointestinal Cancer Research

Volumn 6, Issue 5-6, 2013, Pages 137-143

  Parekh, Arti ^a,b   Truong, Minh Tam ^a   Pashtan, Itai ^b   Qureshi, Muhammad M ^a   Martin, Neil E ^c   Nawaz, Omer ^d   Cerda, Sandra ^e   Willins, John ^a   Hartshorn, Kevan L ^e   Kachnic, Lisa A ^a  

^a Department of Radiation Oncology ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Paoli Cancer Center   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

3 DIMENSIONAL CONFORMAL RADIOTHERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTINUOUS INFUSION; DEHYDRATION; DIARRHEA; DIGITAL RECTAL EXAMINATION; EXCISION; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; PROCTITIS; RECTUM CANCER; RETROSPECTIVE STUDY; SIGMOIDOSCOPE; SMALL INTESTINE OBSTRUCTION; TREATMENT RESPONSE; VOMITING;

EID: 84891638085     PISSN: 19347820     EISSN: 19347987     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. American Cancer Society. Cancer Facts and Figures 2012. Atlanta: American Cancer Society, 2012
2. Wolmark N, Wieand HS, Hyams DM, et al: Randomized trial of postoperative adjuvant chemo- therapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388-396, 2000
3. Roh MS, Colangelo LH, O'Connell MJ, et al: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27: 5124-5130, 2009
4. Sauer R, Becker H, Hohenberger W, et al: Pre-operative versus postoperative chemoradio-therapy for rectal cancer. N Engl J Med 351: 1731-1740, 2004
5. Bosset JF, Collette L, Calais G, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006
6. Tho LM, Glegg M, Paterson J, et al: Acute small bowel toxicity and preoperative chemoradio-therapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66:505-513, 2006
7. Baglan KL, Frazier RC, Yan D, et al: The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52:176-183, 2002
8. Robertson JM, Lockman D, Yan D, et al: The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemo-radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 70:413-418, 2008
9. Fietkau R, Rodel C, Hohenberger W, et al: Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys 67:1008-1019, 2007
10. Gunderson LL, Russell AH, Llewellyn HJ, et al: Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel films. Int J Radiat Oncol Biol Phys 11:1379-1393, 1985
11. Ashman JB, Zelefsky MJ, Hunt MS, et al: Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63:765-771, 2005
12. Mundt AJ, Lujan AE, Rotmensch J, et al: Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Ra-diat Oncol Biol Phys 52:1330-1337, 2002
13. Kachnic LA, Tsai HK, Coen JJ, et al: Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys 82:153-158, 2012
14. Arbea L, Ramos LI, Martinez-Monge R, et al: Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol 5:153-157, 2010
15. Guerrero Urbano MT, Henrys AJ, Adams EJ, et al: Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 65:907-916, 2006
16. Martin NE, Nawaz, AO, Schuller B, et al: Dosi-metric comparison of radiation techniques to the prone pelvis for rectal cancer: 3-field based on bony landmarks (2D) vs. 3-dimensonal con-formal (3D) vs. intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 72:907- S548, 2008
17. RTOG 0822, a phase II evaluation of preopera-tive chemoradiotherapy utilizing intensity modulated radiation therapy (IMRT) in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 81:S3-S4, 2011
18. International Commission on Radiation Units and Measurements: Prescribing, recording and reporting photon beam therapy. Report 50. Be-thesda, MD: ICRU, 1993
19. Myerson RJ, Garofalo MC, El Naqa I, et al: Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74:824-830, 2009
20. Samuelian JM, Callister MD, Ashman JB, et al: Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 82:1981- 1987, 2012
21. Engels B, De Ridder M, Tournel K, et al: Preop-erative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 74:1476-1480, 2009
22. Kim JY, Kim DY, Kim TH, et al: Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis 22:373-379, 2007
23. Resch G, De Vries A, Ofner D, et al: Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer: a 2 stage phase II clinical trial. Ra-diother Oncol 102:10-13, 2012
24. Wong SJ, Winter K, Meropol NJ, et al: Radiation Therapy Oncology Group 0247: a randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 82:1367-1375, 2012